T1	tradename 0 7	DEPOCYT
T3	activeingredient 9 19	cytarabine
T5	nanoparticle 20 28	liposome
T7	tradename 155 169	DEPOCYT safely
T9	tradename 224 241	DEPOCYT.  DEPOCYT
T11	activeingredient 243 253	cytarabine
T13	nanoparticle 254 262	liposome
T15	routeofadministration 280 291	Intrathecal
T17	fdaapprovaldate 324 328	1999
T19	tradename 443 444	 
T21	adversereaction 444 466	Chemical arachnoiditis
T23	adversereaction 503 509	nausea
T25	adversereaction 511 519	vomiting
T27	adversereaction 521 529	headache
T29	adversereaction 534 539	fever
T31	adversereaction 613 635	chemical arachnoiditis
T33	tradename 669 676	DepoCyt
T35	co-administereddrug 713 726	dexamethasone
T37	adversereaction 755 778	chemical arachnoiditis.
T39	tradename 869 877	 DepoCyt
T41	routeofadministration 899 910	intrathecal
T43	indication 924 948	lymphomatous meningitis.
T45	tradename 1025 1033	 DepoCyt
T47	routeofadministration 1041 1052	intrathecal
T49	tradename 1089 1096	DepoCyt
T51	dose 1098 1103	50 mg
T53	routeofadministration 1116 1129	intrathecally
T55	frequency 1168 1181	every 14 days
T57	tradename 1240 1247	DepoCyt
T59	dose 1249 1254	50 mg
T61	routeofadministration 1267 1280	intrathecally
T63	frequency 1319 1332	every 14 days
T65	tradename 1424 1431	DepoCyt
T67	dose 1433 1438	50 mg
T69	routeofadministration 1451 1464	intrathecally
T71	frequency 1503 1516	every 28 days
T73	co-administereddrug 1571 1584	dexamethasone
T75	dose 1585 1589	4 mg
T77	frequency 1590 1601	twice a day
T79	routeofadministration 1609 1617	by mouth
T81	routeofadministration 1621 1634	intravenously
T83	tradename 1670 1677	DepoCyt
T85	tradename 1737 1744	DepoCyt
T87	dose 1748 1754	25 mg.
T89	tradename 1794 1802	DepoCyt.
T91	activeingredient 1933 1943	cytarabine
T93	nanoparticle 1944 1952	liposome
T95	activeingredient 2065 2075	cytarabine
T97	adversereaction 2237 2247	Myelopathy
T99	tradename 2320 2328	DepoCyt.
T101	tradename 2459 2467	DepoCyt.
T103	adversereaction 2614 2622	headache
T105	adversereaction 2624 2637	arachnoiditis
T107	adversereaction 2639 2648	confusion
T109	adversereaction 2650 2663	abnormal gait
T111	adversereaction 2666 2677	convulsions
T113	adversereaction 2679 2687	weakness
T115	adversereaction 2689 2696	pyrexia
T117	adversereaction 2698 2705	fatigue
T119	adversereaction 2707 2713	nausea
T121	adversereaction 2715 2723	vomiting
T123	adversereaction 2726 2738	constipation
T125	adversereaction 2744 2754	back pain.
T127	company 2809 2818	Sigma-Tau
T129	tradename 2820 2820	
T131	company 2820 2835	Pharmaceuticals
T133	company 2837 2841	Inc.
T135	adversereaction 3316 3338	Chemical Arachnoiditis
T137	adversereaction 4212 4234	CHEMICAL ARACHNOIDITIS
T139	tradename 4254 4255	 
T141	adversereaction 4255 4277	Chemical arachnoiditis
T143	adversereaction 4314 4320	nausea
T145	adversereaction 4322 4330	vomiting
T147	adversereaction 4332 4340	headache
T149	adversereaction 4345 4350	fever
T151	adversereaction 4424 4446	chemical arachnoiditis
T153	tradename 4480 4487	DepoCyt
T155	co-administereddrug 4524 4537	dexamethasone
T157	adversereaction 4566 4589	chemical arachnoiditis.
T159	tradename 4658 4668	 DepoCyt (
T161	activeingredient 4668 4678	cytarabine
T163	nanoparticle 4679 4687	liposome
T165	routeofadministration 4720 4731	intrathecal
T167	indication 4745 4769	lymphomatous meningitis.
T169	tradename 4849 4857	 DepoCyt
T171	tradename 4972 4982	DepoCyt. 
T173	tradename 5019 5026	DepoCyt
T175	tradename 5246 5253	DepoCyt
T177	tradename 5311 5318	DepoCyt
T179	tradename 5501 5508	DepoCyt
T181	tradename 5578 5585	DepoCyt
T183	tradename 5648 5655	DepoCyt
T185	tradename 5890 5897	DepoCyt
T187	tradename 6004 6020	DepoCyt. DepoCyt
T189	routeofadministration 6121 6158	direct injection into the lumbar sac.
T191	tradename 6160 6167	DepoCyt
T193	indication 6451 6474	lymphomatous meningitis
T195	tradename 6476 6483	DepoCyt
T197	dose 6484 6489	50 mg
T199	tradename 6503 6511	DepoCyt)
T201	tradename 6595 6602	DepoCyt
T203	dose 6604 6609	50 mg
T205	routeofadministration 6624 6637	intrathecally
T207	routeofadministration 6659 6675	lumbar puncture)
T209	frequency 6676 6689	every 14 days
T211	tradename 6742 6749	DepoCyt
T213	dose 6751 6756	50 mg
T215	routeofadministration 6771 6784	intrathecally
T217	routeofadministration 6806 6822	lumbar puncture)
T219	frequency 6823 6836	every 14 days
T221	tradename 6923 6930	DepoCyt
T223	dose 6932 6937	50 mg
T225	routeofadministration 6952 6965	intrathecally
T227	routeofadministration 6987 7003	lumbar puncture)
T229	frequency 7004 7017	every 28 days
T231	co-administereddrug 7088 7101	dexamethasone
T233	dose 7102 7106	4 mg
T235	frequency 7107 7118	twice a day
T237	routeofadministration 7126 7134	by mouth
T239	routeofadministration 7138 7151	intravenously
T241	duration 7156 7162	5 days
T243	tradename 7187 7194	DepoCyt
T245	dose 7277 7283	25 mg.
T247	tradename 7315 7322	DepoCyt
T249	activeingredient 7447 7457	cytarabine
T251	nanoparticle 7458 7466	liposome
T253	tradename 7502 7512	 DepoCyt (
T255	activeingredient 7512 7522	cytarabine
T257	nanoparticle 7523 7531	liposome
T259	activeingredient 7600 7610	cytarabine
T261	adversereaction 7730 7752	Chemical Arachnoiditis
T263	tradename 7754 7755	 
T265	adversereaction 7755 7777	Chemical arachnoiditis
T267	adversereaction 7814 7820	nausea
T269	adversereaction 7822 7830	vomiting
T271	adversereaction 7832 7840	headache
T273	adversereaction 7845 7850	fever
T275	adversereaction 7904 7926	chemical arachnoiditis
T277	adversereaction 8026 8048	chemical arachnoiditis
T279	adversereaction 8094 8116	chemical arachnoiditis
T281	tradename 8190 8197	DepoCyt
T283	co-administereddrug 8234 8247	dexamethasone
T285	adversereaction 8276 8298	chemical arachnoiditis
T287	routeofadministration 8574 8585	intrathecal
T289	tradename 8599 8606	DepoCyt
T291	adversereaction 8663 8677	neurotoxicity.
T293	adversereaction 8699 8712	neurotoxicity
T295	tradename 8741 8751	DepoCyt. 
T297	tradename 8790 8797	DepoCyt
T299	tradename 8836 8836	
T301	adversereaction 8836 8849	Hydrocephalus
T303	adversereaction 8899 8913	arachnoiditis.
T305	tradename 8915 8915	
T307	adversereaction 8915 8928	Arachnoiditis
T309	routeofadministration 9013 9024	intrathecal
T311	adversereaction 9085 9098	arachnoiditis
T313	tradename 9121 9128	DepoCyt
T315	indication 9195 9219	lymphomatous meningitis.
T317	adversereaction 9254 9276	chemical arachnoiditis
T319	co-administereddrug 9316 9329	dexamethasone
T321	co-administereddrug 9360 9373	dexamethasone
T323	adversereaction 9392 9414	chemical arachnoiditis
T325	adversereaction 9451 9464	Neurotoxicity
T327	tradename 9466 9467	 
T329	routeofadministration 9467 9478	Intrathecal
T331	activeingredient 9497 9507	cytarabine
T333	adversereaction 9518 9528	myelopathy
T335	adversereaction 9539 9558	neurologic toxicity
T337	routeofadministration 9632 9643	intrathecal
T339	activeingredient 9644 9654	cytarabine
T341	adversereaction 9766 9780	neurotoxicity.
T343	activeingredient 9832 9842	cytarabine
T345	adversereaction 9894 9908	neurotoxicity.
T347	routeofadministration 9933 9944	intrathecal
T349	routeofadministration 10073 10084	intrathecal
T351	tradename 10103 10110	DepoCyt
T353	adversereaction 10112 10143	central nervous system toxicity
T355	adversereaction 10155 10184	persistent extreme somnolence
T357	adversereaction 10186 10196	hemiplegia
T359	adversereaction 10198 10217	visual disturbances
T361	adversereaction 10228 10237	blindness
T363	adversereaction 10272 10280	deafness
T365	adversereaction 10285 10306	cranial nerve palsies
T367	adversereaction 10349 10370	peripheral neuropathy
T369	adversereaction 10380 10384	pain
T371	adversereaction 10386 10394	numbness
T373	adversereaction 10396 10407	paresthesia
T375	adversereaction 10409 10417	weakness
T377	adversereaction 10423 10457	impaired bowel and bladder control
T379	adversereaction 10569 10591	Cauda Equina Syndrome.
T381	adversereaction 10613 10626	neurotoxicity
T383	tradename 10655 10662	DepoCyt
T385	tradename 10678 10685	DepoCyt
T387	adversereaction 10686 10694	Headache
T389	adversereaction 10696 10702	nausea
T391	adversereaction 10708 10713	fever
T393	adversereaction 10745 10759	neurotoxicity.
T395	tradename 10934 10941	DepoCyt
T397	tradename 10986 10987	 
T399	activeingredient 10987 10997	Cytarabine
T401	tradename 11023 11030	DepoCyt
T403	activeingredient 11136 11146	cytarabine
T405	routeofadministration 11157 11168	intrathecal
T407	tradename 11187 11194	DepoCyt
T409	tradename 11211 11211	
T411	activeingredient 11211 11221	Cytarabine
T413	activeingredient 11256 11266	Cytarabine
T415	tradename 11681 11681	
T417	adversereaction 11681 11703	Chemical Arachnoiditis
T419	tradename 11742 11742	
T421	adversereaction 11742 11755	Neurotoxicity
T423	tradename 11794 11794	
T425	adversereaction 11794 11855	Transient elevations in CSF protein and CSF white blood cells
T427	routeofadministration 11941 11952	intrathecal
T429	activeingredient 11971 11981	cytarabine
T431	adversereaction 12042 12050	headache
T433	adversereaction 12056 12062	nausea
T435	adversereaction 12064 12072	vomiting
T437	adversereaction 12078 12091	arachnoiditis
T439	adversereaction 12093 12101	weakness
T441	adversereaction 12103 12112	confusion
T443	adversereaction 12114 12121	pyrexia
T445	adversereaction 12123 12130	fatigue
T447	adversereaction 12132 12144	constipation
T449	adversereaction 12146 12155	back pain
T451	adversereaction 12157 12170	gait abnormal
T453	adversereaction 12176 12187	convulsions
T455	adversereaction 12193 12202	dizziness
T457	adversereaction 12208 12216	lethargy
T459	adversereaction 12218 12230	pain in limb
T461	adversereaction 12232 12240	insomnia
T463	adversereaction 12242 12265	urinary tract infection
T465	adversereaction 12271 12280	neck pain
T467	adversereaction 12282 12287	death
T469	adversereaction 12293 12297	pain
T471	adversereaction 12299 12316	memory impairment
T473	adversereaction 12318 12329	dehydration
T475	adversereaction 12331 12337	anemia
T477	adversereaction 12343 12351	diarrhea
T479	adversereaction 12357 12375	appetite decreased
T481	adversereaction 12381 12397	thrombocytopenia
T483	adversereaction 12399 12415	edema peripheral
T485	adversereaction 12417 12427	arthralgia
T487	adversereaction 12429 12443	neck stiffness
T489	adversereaction 12445 12459	vision blurred
T491	adversereaction 12461 12476	muscle weakness
T493	adversereaction 12478 12489	neutropenia
T495	adversereaction 12491 12503	hypoesthesia
T497	adversereaction 12505 12514	agitation
T499	adversereaction 12520 12527	dyspnea
T501	indication 13243 13266	lymphomatous meningitis
T503	tradename 13277 13284	DepoCyt
T505	dose 13285 13290	50 mg
T507	tradename 13366 13373	DepoCyt
T509	tradename 13382 13389	DepoCyt
T511	tradename 13438 13439	 
T513	adversereaction 13439 13447	Headache
T515	tradename 13480 13480	
T517	adversereaction 13480 13493	Arachnoiditis
T519	tradename 13523 13523	
T521	adversereaction 13523 13532	Confusion
T523	tradename 13561 13561	
T525	adversereaction 13561 13574	Gait abnormal
T527	tradename 13606 13606	
T529	adversereaction 13606 13617	Convulsions
T531	tradename 13647 13647	
T533	adversereaction 13647 13656	Dizziness
T535	tradename 13687 13687	
T537	adversereaction 13687 13704	Memory impairment
T539	tradename 13730 13730	
T541	adversereaction 13730 13742	Hypoesthesia
T543	tradename 13769 13769	
T545	adversereaction 13769 13775	Tremor
T547	tradename 13801 13801	
T549	adversereaction 13801 13822	Peripheral neuropathy
T551	tradename 13850 13850	
T553	adversereaction 13850 13857	Syncope
T555	tradename 13882 13882	
T557	adversereaction 13882 13892	Neuropathy
T559	tradename 13921 13921	
T561	adversereaction 13921 13950	Peripheral sensory neuropathy
T563	tradename 13975 13975	
T565	adversereaction 13975 13992	Reflexes abnormal
T567	tradename 14072 14073	 
T569	adversereaction 14073 14081	Weakness
T571	tradename 14111 14111	
T573	adversereaction 14111 14118	Pyrexia
T575	tradename 14147 14147	
T577	adversereaction 14147 14154	Fatigue
T579	tradename 14182 14182	
T581	adversereaction 14182 14190	Lethargy
T583	tradename 14217 14217	
T585	adversereaction 14217 14222	Death
T587	tradename 14253 14254	 
T589	adversereaction 14254 14262	Lymphoma
T591	tradename 14303 14310	DepoCyt
T593	tradename 14319 14326	DepoCyt
T595	tradename 14348 14349	 
T597	adversereaction 14349 14353	Pain
T599	tradename 14383 14383	
T601	adversereaction 14383 14399	Edema peripheral
T603	tradename 14427 14427	
T605	adversereaction 14427 14431	Fall
T607	tradename 14456 14456	
T609	adversereaction 14456 14476	Mucosal inflammation
T611	tradename 14504 14504	
T613	adversereaction 14504 14509	Edema
T615	tradename 14565 14565	
T617	adversereaction 14565 14571	Nausea
T619	tradename 14601 14601	
T621	adversereaction 14601 14609	Vomiting
T623	tradename 14642 14642	
T625	adversereaction 14642 14654	Constipation
T627	tradename 14681 14681	
T629	adversereaction 14681 14689	Diarrhea
T631	tradename 14720 14720	
T633	adversereaction 14720 14734	Abdominal pain
T635	tradename 14764 14764	
T637	adversereaction 14764 14773	Dysphagia
T639	tradename 14799 14799	
T641	adversereaction 14799 14810	Hemorrhoids
T643	tradename 14885 14885	
T645	adversereaction 14885 14894	Back pain
T647	tradename 14921 14921	
T649	adversereaction 14921 14933	Pain in limb
T651	tradename 14960 14960	
T653	adversereaction 14960 14969	Neck pain
T655	tradename 14996 14996	
T657	adversereaction 14996 15006	Arthralgia
T659	tradename 15032 15032	
T661	adversereaction 15032 15046	Neck stiffness
T663	tradename 15072 15072	
T665	adversereaction 15072 15087	Muscle weakness
T667	tradename 15140 15140	
T669	adversereaction 15140 15148	Insomnia
T671	tradename 15175 15175	
T673	adversereaction 15175 15184	Agitation
T675	tradename 15210 15210	
T677	adversereaction 15210 15220	Depression
T679	tradename 15246 15246	
T681	adversereaction 15246 15253	Anxiety
T683	tradename 15307 15307	
T685	adversereaction 15307 15330	Urinary tract infection
T687	tradename 15361 15361	
T689	adversereaction 15361 15370	Pneumonia
T691	tradename 15435 15435	
T693	adversereaction 15435 15446	Dehydration
T695	tradename 15473 15473	
T697	adversereaction 15473 15491	Appetite decreased
T699	tradename 15522 15522	
T701	adversereaction 15522 15534	Hyponatremia
T703	tradename 15559 15559	
T705	adversereaction 15559 15570	Hypokalemia
T707	tradename 15595 15595	
T709	adversereaction 15595 15608	Hyperglycemia
T711	tradename 15633 15633	
T713	adversereaction 15633 15641	Anorexia
T715	tradename 15682 15682	
T717	adversereaction 15682 15706	Platelet count decreased
T719	tradename 15760 15760	
T721	adversereaction 15760 15772	Incontinence
T723	tradename 15801 15801	
T725	adversereaction 15801 15818	Urinary retention
T727	tradename 15893 15893	
T729	adversereaction 15893 15900	Dyspnea
T731	tradename 15931 15931	
T733	adversereaction 15931 15936	Cough
T735	tradename 15976 15976	
T737	adversereaction 15976 15990	Vision blurred
T739	tradename 16048 16048	
T741	adversereaction 16048 16054	Anemia
T743	tradename 16085 16085	
T745	adversereaction 16085 16101	Thrombocytopenia
T747	tradename 16178 16185	DepoCyt
T749	tradename 16194 16201	DepoCyt
T751	tradename 16223 16224	 
T753	adversereaction 16224 16235	Neutropenia
T755	tradename 16304 16305	 
T757	adversereaction 16305 16314	Contusion
T759	tradename 16339 16339	
T761	adversereaction 16339 16347	Pruritus
T763	tradename 16375 16375	
T765	adversereaction 16375 16393	Sweating increased
T767	tradename 16438 16438	
T769	adversereaction 16438 16449	Hypotension
T771	tradename 16478 16478	
T773	adversereaction 16478 16490	Hypertension
T775	tradename 16548 16548	
T777	adversereaction 16548 16557	Hypacusis
T779	tradename 16602 16602	
T781	adversereaction 16602 16613	Tachycardia
T783	tradename 16712 16712	
T785	adversereaction 16712 16741	Diffuse Large B-Cell Lymphoma
T787	tradename 16912 16919	DepoCyt
T789	dose 16920 16925	50 mg
T791	tradename 16987 16995	 DepoCyt
T793	tradename 17055 17057	 
T795	adversereaction 17057 17065	Headache
T797	tradename 17098 17098	
T799	adversereaction 17098 17111	Arachnoiditis
T801	tradename 17141 17141	
T803	adversereaction 17141 17152	Convulsions
T805	tradename 17211 17211	
T807	adversereaction 17211 17217	Nausea
T809	tradename 17246 17246	
T811	adversereaction 17246 17254	Vomiting
T813	tradename 17336 17336	
T815	adversereaction 17336 17345	Back pain
T817	tradename 17372 17372	
T819	adversereaction 17372 17381	Neck pain
T821	tradename 17406 17406	
T823	adversereaction 17406 17420	Neck stiffness
T825	tradename 17499 17499	
T827	adversereaction 17499 17506	Pyrexia
T829	tradename 17658 17665	DepoCyt
T831	adversereaction 17722 17728	deaths
T833	tradename 17740 17747	DepoCyt
T835	dose 17782 17788	125 mg
T837	adversereaction 17808 17822	encephalopathy
T839	routeofadministration 17851 17867	intraventricular
T841	tradename 17876 17886	DepoCyt. 
T843	tradename 18051 18058	DepoCyt
T845	dose 18060 18065	50 mg
T847	routeofadministration 18073 18089	intraventricular
T849	adversereaction 18110 18124	focal seizures
T851	adversereaction 18140 18159	status epilepticus.
T853	adversereaction 18302 18310	seizures
T855	tradename 18329 18336	DepoCyt
T857	activeingredient 18369 18379	cytarabine
T859	adversereaction 18405 18410	death
T861	tradename 18472 18480	DepoCyt.
T863	tradename 18680 18690	DepoCyt.  
T865	tradename 18784 18791	DepoCyt
T867	tradename 18860 18867	DepoCyt
T869	routeofadministration 18921 18932	intrathecal
T871	routeofadministration 18967 18978	intrathecal
T873	activeingredient 18979 18989	cytarabine
T875	routeofadministration 19030 19043	intrathecally
T877	adversereaction 19054 19067	neurotoxicity
T879	tradename 19289 19299	DepoCyt. 
T881	activeingredient 19324 19334	cytarabine
T883	routeofadministration 19345 19356	intrathecal
T885	tradename 19375 19382	DepoCyt
T887	activeingredient 19398 19408	Cytarabine
T889	activeingredient 19609 19619	cytarabine
T891	tradename 19775 19786	DepoCyt. 
T893	tradename 19961 19962	 
T895	activeingredient 19962 19972	Cytarabine
T897	dose 20080 20087	2 mg/kg
T899	frequency 20087 20091	/day
T901	routeofadministration 20110 20112	IP
T903	dose 20250 20258	20 mg/kg
T905	routeofadministration 20288 20290	IP
T907	routeofadministration 20388 20390	IP
T909	dose 20400 20408	50 mg/kg
T911	tradename 20589 20591	 
T913	activeingredient 20591 20601	Cytarabine
T915	dose 20744 20753	0.5 mg/kg
T917	frequency 20753 20757	/day
T919	dose 20896 20903	8 mg/kg
T921	frequency 20903 20907	/day
T923	activeingredient 21023 21033	cytarabine
T925	routeofadministration 21070 21081	intrathecal
T927	tradename 21082 21089	DepoCyt
T929	activeingredient 21137 21147	cytarabine
T931	routeofadministration 21158 21169	intrathecal
T933	tradename 21185 21192	DepoCyt
T935	tradename 21529 21536	DepoCyt
T937	tradename 21690 21697	DepoCyt
T939	tradename 21758 21765	DepoCyt
T941	activeingredient 21770 21780	cytarabine
T943	nanoparticle 21781 21789	liposome
T945	tradename 21839 21846	DepoCyt
T947	adversereaction 21877 21899	chemical arachnoiditis
T949	adversereaction 21910 21925	encephalopathy.
T951	co-administereddrug 21966 21979	dexamethasone
T953	dose 22012 22018	125 mg
T955	routeofadministration 22075 22086	intrathecal
T957	tradename 22087 22094	DepoCyt
T959	activeingredient 22113 22123	cytarabine
T961	tradename 22138 22148	DepoCyt. 
T963	routeofadministration 22219 22230	intrathecal
T965	activeingredient 22248 22258	cytarabine
T967	tradename 22314 22321	DepoCyt
T969	tradename 22425 22435	 DepoCyt (
T971	activeingredient 22435 22445	cytarabine
T973	nanoparticle 22446 22454	liposome
T975	chemoclass 22509 22523	antimetabolite
T977	activeingredient 22524 22534	cytarabine
T979	routeofadministration 22539 22550	intrathecal
T981	activeingredient 22590 22600	cytarabine
T983	molecularweight 22761 22774	243.22 g/mol.
T985	activeingredient 22775 22785	Cytarabine
T987	tradename 22825 22832	DepoCyt
T989	activeingredient 22904 22915	cytarabine.
T991	tradename 22916 22923	DepoCyt
T993	activeingredient 23000 23010	cytarabine
T995	nanoparticle 23011 23020	liposomes
T997	inactiveingredient 23033 23048	sodium chloride
T999	inactiveingredient 23052 23057	water
T1001	activeingredient 23098 23108	cytarabine
T1003	corecomposition 23117 23128	cholesterol
T1005	corecomposition 23154 23188	dioleoylphosphatidylcholine (DOPC)
T1007	corecomposition 23201 23240	dipalmitoylphosphatidylglycerol (DPPG).
T1009	tradename 23242 23249	DepoCyt
T1011	tradename 23336 23336	
T1013	nanoparticle 23336 23344	Liposome
T1015	activeingredient 23424 23434	cytarabine
T1017	nanoparticle 23435 23443	liposome
T1019	activeingredient 23539 23550	cytarabine.
T1021	tradename 23604 23612	 DepoCyt
T1023	activeingredient 23614 23624	cytarabine
T1025	nanoparticle 23625 23633	liposome
T1027	activeingredient 23705 23715	cytarabine
T1029	tradename 23788 23788	
T1031	activeingredient 23788 23798	Cytarabine
T1033	activeingredient 23928 23938	cytarabine
T1035	activeingredient 23957 23968	cytarabine-
T1037	activeingredient 24218 24228	cytarabine
T1039	activeingredient 24243 24253	Cytarabine
T1041	routeofadministration 24347 24358	intrathecal
T1043	tradename 24377 24384	DepoCyt
T1045	dose 24385 24390	50 mg
T1047	activeingredient 24416 24426	cytarabine
T1049	tmax 24441 24454	within 1 hour
T1051	cmax 24481 24497	30 to 50 mcg/mL.
T1053	activeingredient 24539 24549	cytarabine
T1055	plasmahalflife 24565 24583	5.9 to 82.4 hours.
T1057	activeingredient 24606 24616	cytarabine
T1059	routeofadministration 24642 24653	intrathecal
T1061	tradename 24672 24679	DepoCyt
T1063	dose 24680 24686	50 mg.
T1065	activeingredient 24753 24763	cytarabine
T1067	activeingredient 24892 24902	cytarabine
T1069	routeofadministration 24994 25005	intrathecal
T1071	activeingredient 25139 25149	cytarabine
T1073	tradename 25384 25394	DepoCyt. 
T1075	activeingredient 25394 25404	Cytarabine
T1077	tradename 25620 25620	
T1079	activeingredient 25620 25630	Cytarabine
T1081	activeingredient 25745 25755	cytarabine
T1083	tradename 25803 25803	
T1085	activeingredient 25803 25813	Cytarabine
T1087	routeofadministration 25953 25955	IP
T1089	activeingredient 25956 25967	cytarabine.
T1091	activeingredient 26006 26016	cytarabine
T1093	routeofadministration 26027 26038	intrathecal
T1095	tradename 26054 26061	DepoCyt
T1097	tradename 26127 26134	DepoCyt
T1099	tradename 26178 26186	 DepoCyt
T1101	activeingredient 26188 26198	cytarabine
T1103	dose 26492 26497	50 mg
T1105	tradename 26501 26508	DepoCyt
T1107	frequency 26522 26535	every 2 weeks
T1109	routeofadministration 26548 26559	intrathecal
T1111	frequency 26586 26598	twice a week
T1113	dose 26712 26717	50 mg
T1115	activeingredient 26736 26746	cytarabine
T1117	frequency 26753 26766	twice a week.
T1119	tradename 26803 26810	DepoCyt
T1121	activeingredient 26815 26826	cytarabine)
T1123	tradename 27671 27678	DepoCyt
T1125	tradename 27897 27904	DepoCyt
T1127	activeingredient 27930 27940	cytarabine
T1129	tradename 28304 28311	DepoCyt
T1131	activeingredient 28315 28326	cytarabine.
T1133	tradename 28377 28384	DepoCyt
T1135	duration 28385 28390	50 mg
T1137	frequency 28391 28404	every 2 weeks
T1139	activeingredient 28408 28418	cytarabine
T1141	dose 28419 28424	50 mg
T1143	frequency 28425 28438	twice weekly.
T1145	tradename 28490 28497	DepoCyt
T1147	dose 28498 28503	50 mg
T1149	frequency 28504 28517	every 4 weeks
T1151	activeingredient 28522 28532	cytarabine
T1153	dose 28533 28538	50 mg
T1155	frequency 28539 28545	weekly
T1157	duration 28550 28558	4 weeks.
T1159	co-administereddrug 28621 28634	dexamethasone
T1161	adversereaction 28672 28694	chemical arachnoiditis
T1163	indication 28919 28942	lymphomatous meningitis
T1165	indication 29023 29046	Lymphomatous Meningitis
T1167	tradename 29047 29056	 DepoCyt
T1169	activeingredient 29057 29067	Cytarabine
T1171	tradename 29363 29370	DepoCyt
T1173	activeingredient 29372 29382	cytarabine
T1175	nanoparticle 29383 29391	liposome
T1177	tradename 29739 29748	 DepoCyt
T1179	adversereaction 29938 29946	headache
T1181	adversereaction 29948 29954	nausea
T1183	adversereaction 29956 29964	vomiting
T1185	adversereaction 29970 29975	fever
T1187	adversereaction 30019 30033	neurotoxicity.
T1189	co-administereddrug 30083 30096	dexamethasone
T1191	tradename 30168 30175	DepoCyt
T1193	co-administereddrug 30259 30272	neurotoxicity
T1195	routeofadministration 30288 30292	oral
T1197	co-administereddrug 30293 30306	dexamethasone
T1199	company 30368 30393	Sigma-Tau Pharmaceuticals
T1201	company 30395 30399	Inc.
T1203	tradename 30439 30439	
T1205	company 30439 30461	Pacira Pharmaceuticals
T1207	company 30463 30467	Inc.
T1209	company 30507 30532	Sigma-Tau Pharmaceuticals
T1211	company 30534 30538	Inc.
T1213	tradename 30583 30583	
T1215	u.s.patent 30583 30584	5
T1217	u.s.patent 30585 30588	807
T1219	u.s.patent 30589 30592	572
T1221	tradename 30594 30594	
T1223	u.s.patent 30594 30595	5
T1225	u.s.patent 30596 30599	723
T1227	u.s.patent 30600 30603	147
T1229	tradename 30605 30605	
T1231	u.s.patent 30605 30606	5
T1233	u.s.patent 30607 30610	455
T1235	u.s.patent 30611 30614	044
T1237	tradename 30616 30616	
T1239	u.s.patent 30616 30617	5
T1241	u.s.patent 30618 30621	891
T1243	u.s.patent 30622 30625	467
